aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Crossbow Therapeutics, founded as a seed-stage, stealth-mode oncology startup, is dedicated to revolutionizing cancer treatment through advanced antibody engineering. The company's core mission is to develop potent and precise therapies that can target a wide array of cancer antigens, aiming to cure cancer. Their innovative approach focuses on expanding the reach and impact of antibody therapeutics, embodying the precision and power suggested by their name.
Notable affiliated individuals include a team of experts urgently working to create a comprehensive arsenal of cancer-targeting therapeutics. Although specific investors and key achievements are not publicly disclosed due to the company's stealth mode, Crossbow Therapeutics' commitment to innovation in oncology has the potential to significantly impact the field of cancer treatment by providing more effective and targeted therapeutic options.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Cancer Therapies
Technology
Biotech, Antibody Engineering
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Americas
When was Crossbow Therapeutics founded?
Crossbow Therapeutics was founded in 2021.
Where is Crossbow Therapeutics's headquarters located?
Crossbow Therapeutics's headquarters is located in Cambridge, MA, US.
When was Crossbow Therapeutics's last funding round?
Crossbow Therapeutics's most recent funding round was for $80M (USD) in July 2023.
How many employees does Crossbow Therapeutics have?
Crossbow Therapeutics has 11 employees as of Feb 5, 2024.
How much has Crossbow Therapeutics raised to-date?
As of July 05, 2023, Crossbow Therapeutics has raised a total of $80M (USD) since Jul 11, 2023.
Add Comparison
Total Raised to Date
$80M
USD
Last Update Jul 11, 2023
Last Deal Details
$80M
USD
Jul 11, 2023
Series A
Total Employees Over Time
11
As of Feb 2024
Crossbow Therapeutics Address
450 Kendall Street
Cambridge,
Massachusetts
02142
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts